Swiss Neuro-Oncology meeting

Symposium
Herbstsemester 2016
Klinisches Neurozentrum und Tumorzentrum
Swiss Neuro-Oncology meeting
Freitag, 01. Juli 2016, 09.15 – 17.00 Uhr
Hörsaal Monakow, UniversitätsSpital Zürich, Frauenklinikstrasse 26,
8091 Zürich
Immunotherapy
Chair: PD Dr. N. Andratschke (Department of Radiation Oncology, USZ)
09.15 h
Welcome / Introduction
PD Dr. P. Roth (Department of Neurology, USZ)
09.20 h
EORTC Brain Tumor Group: current and future trials
Prof. Dr. M. Weller (Department of Neurology, USZ)
09.45 h
Can checkpoint inhibition overcome the immunosuppressive microenvironment?
PD Dr. P. Roth (Department of Neurology, USZ)
10.15 h
Novel vaccination approaches
Prof. Dr. P.-Y. Dietrich (University Hospital Geneva)
10.45 h
Coffee break
Clinical Updates
Chair: Prof. Dr. P.-Y. Dietrich (University Hospital Geneva)
11.15 h
Brain metastasis
Prof. Dr. M. Preusser (University of Vienna)
11.45 h
Primary CNS lymphoma
PD Dr. A. Hottinger (CHUV Lausanne)
12.00 h
Ependymoma
Prof. Dr. M. Grotzer (Children‘s Hospital Zürich)
12.15 h
Radiation doses and prevention of toxicity
Dr. G. Pesce (Regional Hospital Bellinzona)
Lunch
Die Fortbildung wird freundlicherweise unterstützt von
Novocure GmbH, Bristol-Myers Squibb SA, AbbVie AG, MSD Merck Sharp & Dohme AG
Organisation: PD Dr. Patrick Roth, Klinik für Neurologie USZ
Tel. 044 255 55 11, [email protected]
Credits: (SNG, SGMO, SGN, SRO)
www.fortbildung.usz.ch – Tel. +41 (0)44 255 30 35
Surgical approaches to low-grade gliomas
Chair: Prof. Dr. M. Weller (Department of Neurology, USZ)
13.30 h
The new St. Gallen approach
PD Dr. A. Weyerbrock (Cantonal Hospital St. Gallen)
13.45 h
The Berne approach
Prof. Dr. A. Raabe (University Hospital Berne)
14.00 h
The Zurich approach
Prof. Dr. L. Regli (Department of Neurosurgery, USZ)
14.15 h
Low grade gliomas beyond surgery: primum nihil nocere
Prof. Dr. R. Stupp (Department of Oncology, USZ)
14.30 h
Low grade gliomas beyond surgery: we need aggressive treatments
PD Dr. T. Hundsberger (Cantonal Hospital, St. Gallen)
14.45 h
Discussion
Prof. Dr. M. Weller (Department of Neurology, USZ)
15.00 h
Coffee break
Novel developments in neurooncology
Chair: PD Dr. A. Hottinger (CHUV Lausanne)
15.30 h
The new WHO classification: the pathologist’s perspective
Prof. Dr. E. Rushing (Institute of Neuropathology, USZ)
15.50 h
The new WHO classification: the molecular biologist’s perspective
Prof. Dr. M. Hegi (CHUV Lausanne)
16.10 h
Update on RANO activities
Prof. Dr. U. Roelcke (Cantonal Hospital Aarau)
16.30 h
Surrogate endpoints and scales in neurooncology
Dr. S. Hofer (Cantonal Hospital Lucerne)
16.50 h
Closing remarks
Prof. Dr. M. Weller (Department of Neurology, USZ)
Die Fortbildung wird freundlicherweise unterstützt von
Novocure GmbH, Bristol-Myers Squibb SA, AbbVie AG, MSD Merck Sharp & Dohme AG
Organisation: PD Dr. Patrick Roth, Klinik für Neurologie USZ
Tel. 044 255 55 11, [email protected]
Credits: (SNG, SGMO, SGN, SRO)
www.fortbildung.usz.ch – Tel. +41 (0)44 255 30 35

Download Report